SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-001457
Filing Date
2021-08-16
Accepted
2021-08-13 17:42:18
Documents
62
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ovid-20210630.htm   iXBRL 10-Q 2452039
2 EX-10.1 ovid-20210630ex10_1.htm EX-10.1 138261
3 EX-31.1 ovid-20210630ex31_1.htm EX-31.1 17882
4 EX-31.2 ovid-20210630ex31_2.htm EX-31.2 17901
5 EX-32.1 ovid-20210630ex32_1.htm EX-32.1 9325
6 GRAPHIC img41443723_0.jpg GRAPHIC 117442
  Complete submission text file 0000950170-21-001457.txt   8200561

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ovid-20210630_lab.xml EX-101.LAB 391333
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ovid-20210630_pre.xml EX-101.PRE 284553
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ovid-20210630_cal.xml EX-101.CAL 36280
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ovid-20210630_def.xml EX-101.DEF 176495
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ovid-20210630.xsd EX-101.SCH 43385
12 EXTRACTED XBRL INSTANCE DOCUMENT ovid-20210630_htm.xml XML 1343796
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38085 | Film No.: 211173560
SIC: 2834 Pharmaceutical Preparations